HB 2741 updates Oregon’s newborn bloodspot screening laws and related public health laboratory authority. The bill directs the Oregon Health Authority to maintain a state public health laboratory capable of analyzing biological and environmental samples for public health purposes and performing newborn bloodspot screening. It also authorizes the laboratory to provide screening or analysis services for outside entities such as other states, tribal agencies, federal agencies, countries or territories, and licensed health care practitioners, subject to OHA rules.
The bill modernizes Oregon’s newborn screening program by replacing older statutory language focused on phenylketonuria and “metabolic diseases” with a broader newborn bloodspot screening framework. OHA must adopt rules on the conditions screened, specimen collection and delivery, recollection procedures, residual specimen handling, fees, fee waivers, reporting of results, and exemption forms. The bill also requires carriers and coordinated care organizations to cover screening costs, while preserving a religious or philosophical exemption for parents or guardians who sign the required form. Screening-related records that identify infants, parents, guardians, or providers are made confidential and exempt from public disclosure.
Impact
HB 2741 amends ORS 433.285, 433.290, and 433.295 and repeals ORS 431A.750, consolidating and updating Oregon’s newborn screening statutes. It expands the Oregon Health Authority’s rulemaking and administrative responsibilities, establishes fee and fee-waiver authority, and requires health care providers and facilities to follow screening procedures, ensure medically appropriate follow-up care, and report confirmed conditions for quality control. The bill also creates a clearer funding structure by directing screening fees into the Public Health Account for laboratory expenses and by requiring insurance coverage for screening costs.
Sentiment
The bill appears to have broad support and little visible opposition. It passed the House committee unanimously, passed the House floor with only one dissenting vote, passed the Senate committee unanimously, passed the Senate floor unanimously, and then passed House concurrence with only one no vote. The vote pattern suggests the measure was viewed as a routine public health update with strong bipartisan backing.
Contention
The main points of potential contention are the scope of newborn screening requirements, the handling of fees and insurance coverage, and the continued availability of religious or philosophical exemptions. The bill requires coverage by carriers and coordinated care organizations and allows OHA to set fees, but it also bars denial of screening based on inability to pay. Another possible area of concern is confidentiality and the retention/use/release of residual specimens, which OHA must address by rule. No committee transcript indicates significant debate, and the recorded votes show only minimal opposition.